Search Results 121-130 of 15487 for alt

1. First-in-Human Study Of FLX925 In Subjects With Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Serum AST and ALT ≤ 3 x ULN; Serum bilirubin ≤ 2 x ULN unless due to Gilbert's syndrome or hemolysis or considered to be related to leukemia; Serum ...

2. Open-Label Study Of The CDK4/6 Inhibitor SPH4336 In Subjects With Locally Advanced Or Metastatic Liposarcomas - Mayo Clinic

   AST and ALT ≤ 3 x ULN or ≤ 5 x ULN if malignant involvement of the liver. Sterile or willing to use effective contraception (approved hormonal ...

3. A Study To Evaluate Aqueous Humor Dynamic Components - Mayo Clinic

   Study eye cannot have history of any past SLT or ALT glaucoma laser treatments. Study eye(s) cannot have any history of refractive surgery. Study eye(s) ...

4. A Study Of Abemaciclib (LY2835219) In Women With HR+, HER2+ Locally Advanced Or Metastatic Breast Cancer - Mayo Clinic

   ... (ALT) and aspartate aminotransferase (AST) ≤ 3 × ULN. If liver metastases are present, AST and ALT ≤ 5 × ULN are acceptable;; renal: serum creatinine ≤ 1.5 ...

5. Melanoma Relatlimab Nivolumab - Clinical Trials

   Participation eligibility · AST/ALT > 3.0x ULN. · Total bilirubin > 1.5x ULN (except participants with Gilbert Syndrome who must have a total bilirubin level of < ...

6. A Study To Evaluate Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

   the presence of elevated serum CK levels, ALT, or AST, up to 5 times the ULN are acceptable if other liver tests are normal. b. If the total bilirubin ...

7. A Dose Titration Study To Assess The Effects Of SAR407899 In Patients With Microvascular Angina And/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

   ALT >3 times the upper limit of normal (ULN). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up ...

8. Biliary atresia - Diagnosis and treatment - Mayo Clinic

   Mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are liver enzymes. Matrix metalloproteinase-7 (MMP7) testing.

9. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

   ALT and AST \<5 × ULN; 2. Total bilirubin ≤2.5 mg/dL in the absence of Gilbert's Syndrome. 3. Serum albumin ≥2.5 g/dL; 4. International normalized ratio ...

10. Safety And Efficacy Study Of MLN0128 In Combination With Exemestane Or Fulvestrant In Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x ULN (≤ 5 x ...